Washington-headquartered Seagen expects to make around $2.2bn in revenue this year, while Pfizer cements its position in cancer medication.
Read more: Pfizer acquires Seagen for $43bn in biggest deal of the year
Washington-headquartered Seagen expects to make around $2.2bn in revenue this year, while Pfizer cements its position in cancer medication.
Read more: Pfizer acquires Seagen for $43bn in biggest deal of the year
